Luca L’Abbate

812 total citations
20 papers, 316 citations indexed

About

Luca L’Abbate is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Epidemiology. According to data from OpenAlex, Luca L’Abbate has authored 20 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Luca L’Abbate's work include Liver Disease Diagnosis and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Luca L’Abbate is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Luca L’Abbate collaborates with scholars based in Italy, United Kingdom and Spain. Luca L’Abbate's co-authors include Bruno Cacopardo, Leonardo Rizzo, Giuseppe Nunnari, Massimo Attanasio, Antonio Craxı̀, Alessandra Mazzola, Arturo Montineri, Salvatore Petta, Nicola Alessi and V. Di Marco and has published in prestigious journals such as Scientific Reports, The American Journal of Gastroenterology and International Journal of Environmental Research and Public Health.

In The Last Decade

Luca L’Abbate

16 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca L’Abbate Italy 6 215 132 54 53 38 20 316
Golo Petzold Germany 10 150 0.7× 97 0.7× 20 0.4× 24 0.5× 19 0.5× 30 271
Jorge Méndez-Navarro United States 11 387 1.8× 334 2.5× 66 1.2× 15 0.3× 38 1.0× 13 564
Raluca Lupușoru Romania 16 393 1.8× 276 2.1× 68 1.3× 64 1.2× 42 1.1× 54 538
Ruxandra Mare Romania 12 293 1.4× 206 1.6× 58 1.1× 47 0.9× 36 0.9× 41 381
Janne Fuglsang Hansen Denmark 11 479 2.2× 349 2.6× 42 0.8× 74 1.4× 21 0.6× 25 619
Eunju Kim South Korea 12 177 0.8× 160 1.2× 110 2.0× 14 0.3× 25 0.7× 32 424
Stella Maris Martínez Argentina 9 539 2.5× 419 3.2× 48 0.9× 56 1.1× 33 0.9× 20 639
Amr Shaaban Hanafy Egypt 12 161 0.7× 132 1.0× 24 0.4× 49 0.9× 5 0.1× 43 350
Jeanne‐Marie Giard Canada 9 204 0.9× 189 1.4× 57 1.1× 13 0.2× 23 0.6× 25 311

Countries citing papers authored by Luca L’Abbate

Since Specialization
Citations

This map shows the geographic impact of Luca L’Abbate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca L’Abbate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca L’Abbate more than expected).

Fields of papers citing papers by Luca L’Abbate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca L’Abbate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca L’Abbate. The network helps show where Luca L’Abbate may publish in the future.

Co-authorship network of co-authors of Luca L’Abbate

This figure shows the co-authorship network connecting the top 25 collaborators of Luca L’Abbate. A scholar is included among the top collaborators of Luca L’Abbate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca L’Abbate. Luca L’Abbate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
L’Abbate, Luca, Emmanuele A. Jannini, Maria Cristina De Martino, et al.. (2025). Sexual Dysfunctions Associated with Proton Pump Inhibitors: Insights from VigiBase, the World Health Organization Pharmacovigilance Database. Drug Safety. 49(4). 435–447.
2.
Crisafulli, Salvatore, et al.. (2024). Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors. JAMA Network Open. 7(7). e2419851–e2419851. 2 indexed citations
4.
5.
Luxi, Nicoletta, Luca L’Abbate, Florence van Hunsel, et al.. (2024). What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study. Drug Safety. 47(10). 1011–1023. 5 indexed citations
6.
Crisafulli, Salvatore, Ylenia Ingrasciotta, Andrea Fontana, et al.. (2024). Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project. Endocrine. 85(2). 894–905.
7.
Luxi, Nicoletta, Luca L’Abbate, Florence van Hunsel, et al.. (2024). Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study. Vaccines. 12(3). 241–241. 3 indexed citations
8.
Luxi, Nicoletta, Florence van Hunsel, Luca L’Abbate, et al.. (2024). Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study. Vaccines. 12(9). 1059–1059. 1 indexed citations
9.
Ingrasciotta, Ylenia, Valentina Isgrò, Valentina Ientile, et al.. (2023). Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy. Clinical Epidemiology. Volume 15. 309–321. 2 indexed citations
11.
Sultana, Janet, Maria Vadalà, Teresio Avitabile, et al.. (2022). Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy. European Journal of Ophthalmology. 32(5). 3064–3073. 3 indexed citations
12.
Crisafulli, Salvatore, Andrea Fontana, Luca L’Abbate, et al.. (2022). Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases. Scientific Reports. 12(1). 15843–15843. 5 indexed citations
13.
Marcianò, Antonia, Ylenia Ingrasciotta, Valentina Isgrò, et al.. (2021). Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset. Journal of Clinical Medicine. 10(20). 4762–4762. 11 indexed citations
14.
Crisafulli, Salvatore, Valentina Ientile, Luca L’Abbate, et al.. (2021). COVID-19 Patient Management in Outpatient Setting: A Population-Based Study from Southern Italy. Journal of Clinical Medicine. 11(1). 51–51. 11 indexed citations
15.
Panunzi, Simona, Ornella Verrastro, Luca L’Abbate, et al.. (2020). Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis. Diabetes Obesity and Metabolism. 23(4). 980–990. 47 indexed citations
16.
Ingrasciotta, Ylenia, Maria Paola Bertuccio, Salvatore Crisafulli, et al.. (2020). Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy. International Journal of Environmental Research and Public Health. 17(24). 9514–9514. 5 indexed citations
17.
Russo, Marco, Pasqualino Malandrino, Massimo Buscema, et al.. (2020). Combined use of sonographic and elastosonographic parameters can improve the diagnostic accuracy in thyroid nodules at risk of malignancy at cytological examination. PubMed. 45(1). 3–11. 3 indexed citations
18.
Capristo, Esmeralda, Simona Panunzi, Andrea De Gaetano, et al.. (2017). Intensive lifestyle modifications with or without liraglutide 3 mg vs. sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study. Diabetes & Metabolism. 44(3). 235–242. 20 indexed citations
19.
20.
Rizzo, Leonardo, Vincenza Calvaruso, Bruno Cacopardo, et al.. (2011). Comparison of Transient Elastography and Acoustic Radiation Force Impulse for Non-Invasive Staging of Liver Fibrosis in Patients With Chronic Hepatitis C. The American Journal of Gastroenterology. 106(12). 2112–2120. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026